Clinicopathologic factors predicting complete pathological response to neoadjuvant chemoradiotherapy in esophageal cancer
Authors:
- 1 August 2006
- journal article
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 19 (4) , 273-276
Abstract
Summary. Multimodal therapy comprising neoadjuvant chemotherapy and radiation therapy prior to radical resection is increasingly utilized in gastroesophageal cKeywords
This publication has 25 references indexed in Scilit:
- Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysisGut, 2004
- Esophageal CancerNew England Journal of Medicine, 2003
- A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancerThe American Journal of Surgery, 2003
- A pathological study of tumour regression in oesophageal adenocarcinoma treated with preoperative chemoradiotherapyJournal of Clinical Pathology, 2001
- Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancerBritish Journal of Surgery, 2001
- Preoperative Chemoradiotherapy for Esophageal CancerJournal of Clinical Oncology, 2001
- Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the EsophagusNew England Journal of Medicine, 1997
- A Comparison of Multimodal Therapy and Surgery for Esophageal AdenocarcinomaNew England Journal of Medicine, 1996
- Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlationsCancer, 1994
- Growth Rate Patterns of Solid Tumors and Their Relation to Responsiveness to TherapyAnnals of Internal Medicine, 1978